Clinical Trials on Urinary Bladder Neoplasm in Australia
Total 5940 results
-
Asieris Pharmaceuticals (AUS) Pty Ltd.Completed
-
Medical University of ViennaUniversity of Turin, ItalyRecruitingT1 Urinary Bladder CancerAustria
-
David D'AndreaCompleted
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisNot yet recruiting
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
Barmherzige Brüder ViennaCompleted
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaActive, not recruitingBladder CancerAustralia
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaboratorsCompletedSuperficial Bladder CancerUnited States, Australia, New Zealand, Canada, United Kingdom
-
Trans Tasman Radiation Oncology GroupCompletedBladder CancerAustralia, New Zealand
-
Nektar TherapeuticsBristol-Myers SquibbCompletedNeoplasm Metastasis | Urinary Bladder NeoplasmUnited States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
University Teaching Hospital Hall in TirolSalzburger LandesklinikenRecruitingNeoplasms | Urogenital Neoplasms | Transitional Cell Carcinoma | Circulating Tumor Cell | Urinary Bladder NeoplasmAustria
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingBladder CancerCanada, Australia, United States, Poland, Spain
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
David D'AndreaNot yet recruitingBladder Cancer | Upper Urinary Tract Urothelial CarcinomaAustria
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
ViralyticsMerck Sharp & Dohme LLCCompletedBladder Cancer | Non-small Cell Lung CancerUnited States, United Kingdom, Australia
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Institute of Cancer Research, United KingdomTrans Tasman Radiation Oncology GroupActive, not recruitingBladder CancerUnited Kingdom, New Zealand, Australia
-
APOGEPHA Arzneimittel GmbHCompletedUrologic Diseases | Urinary Incontinence | Urinary Bladder, Neurogenic | Neurogenic Urinary Bladder Disorder | Bladder Disorder, Neurogenic | Urinary Bladder Disorder, Neurogenic | Neurogenic Bladder Disorder | Urinary Bladder Neurogenic Dysfunction | Overactive Detrusor FunctionRomania, Austria, Germany
-
Medical Enterprises Europe B.V.TerminatedNeoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary BladderAustria, Israel, Italy, Netherlands
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
AllerganTerminatedOveractive BladderUnited States, Canada, India, Australia
-
Universitätsklinikum Hamburg-EppendorfCancer Research UK; Deutsche Krebshilfe e.V., Bonn (Germany); Australasian Gastro-Intestinal... and other collaboratorsActive, not recruitingCholangiocarcinoma | Gall Bladder CarcinomaGermany, Netherlands, United Kingdom, Australia, Denmark, Italy, New Zealand, Austria
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
CG Oncology, Inc.RecruitingNon Muscular Invasive Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
European Organisation for Research and Treatment...CompletedBladder CancerNetherlands, Belgium, France, Austria, United Kingdom, Israel, Italy, Turkey, Greece, Portugal, Romania
-
Medical University of ViennaRecruitingUrinary Bladder, Overactive | MicrobiotaAustria
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
PhotocureCompletedBladder CancerUnited States, Canada, Austria, Germany, Netherlands
-
Medical University of ViennaCompletedOveractive Bladder | Urinary Incontinence | Pelvic Organ Prolapse | Recurrent Urinary Tract InfectionsAustria
-
PhotocureCompletedBladder CancerUnited States, Canada, Austria, Germany, Netherlands
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Salzburger LandesklinikenUnknownBenign Prostatic Hyperplasia | Bladder Outlet ObstructionAustria, Switzerland
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
SanofiCompletedUrinary Bladder NeoplasmsBelgium, Mexico, Brazil, Chile, Poland, South Africa, Spain, Israel, United States, Argentina, Australia, Canada, France, India, Italy, Netherlands, Russian Federation, Sweden, Turkey
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
MEDA Pharma GmbH & Co. KGRecruitingInterstitial Cystitis and Bladder Pain SyndromeAustria
-
Fusion Pharmaceuticals Inc.TerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Liver Cancer | Bladder Carcinoma | Susceptible FGFR3 Genetic Alterations | FGFR3 | FGFR3 Overexpression | FGFR3 Receptor | FGFR3 Protein OverexpressionUnited States, Australia
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden